About usSign in
Status
ACTIVE
Global HQ
https://www.crunchbase.com/search/organizations/field/organizations/location_identifiers/tokyo-japan
Countries of investment
  • Japan
  • USA
Investment stages
  • Seed
  • Series A
  • Series B
  • Series B
Industries
  • Data
  • Insurance Tech
  • Health tech
  • -
  • Fintech
  • IoT
  • Analytics
About
Aflac Ventures is the corporate venture arm of Aflac, a Fortune 150 company providing financial protection to more than 50 M people worldwide. The firm invests in promising young companies that develop disruptive innovations in insurance, healthcare, finance, analytics, and related fields. Aflac Ventures boasts a strong support network, deep industry expertise, and access to extensive resources, including technology, business platforms, financial backing, and established distribution channels in the U.S. and Japan. Founded in 2016, Aflac Ventures focuses on investing in early to growthstage businesses with disruptive innovations within their ecosystem. It facilitates joint ventures betTheyen Aflac’s business units and startups through Aflac Ventures Lab, focusing on codeveloping and customizing solutions to accelerate innovation in the insurance sector. Its subsidiary, Aflac Ventures Japan, aims to create new Aflac business opportunities and contribute to the growth of its collaborators.
Min check size
$1M
Max check size
$3M
Fund size
NPS

Investment Thesis

Aflac Ventures is a strategic venture capital firm establishing partnerships with gamechanging innovators across multiple disciplines and sectors, focusing on disruptive innovations in insurance, healthcare, finance, analytics, and other related fields. They invest in compelling startups whose ideas and technologies align with Aflac’s strategic interests and focus areas. Their initial investments typically range from $1 M to $3 M, with additional capacity for followons.
Lead investor
Co Invest
Number of exits
Preferred contact method

Aflac Ventures Contacts Information

Primary contact

Secondary contact

Team

Nadeem Khan

Managing Director

Christina Jones

Partner

Mark Harrell

Principal

Jason Meeks

Senior Associate

Portfolio

Better Therapeutics

Bind Benefits

Limelight Health

Medxoom

Wellth

Ginger

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp